Discrepancy Between National Drug Recommendations And Local Uptake in the Swedish Inpatient Sector

Abstract

lating health outcomes were reported in two-thirds of the submissions. However, worst-case scenarios were hardly presented. Compliance with HAS guidelines for exploring methodological uncertainty (e.g. perspective, discounting, time horizon) was fair. However, the choice of the comparator(s)-an essential component of a CEA-was considered problematic in nearly 40% of submissions. ConClusions: Overall, reporting of DSA and PSA is complying with HAS guidelines. More work is needed to explore uncertainty, in particular, to account for correlations between model input parameters and to enhance the analysis of structural uncertainty.